Pasithea Therapeutics Corp. (KTTAW) Gains from Investment Securities (2021 - 2025)

Pasithea Therapeutics has disclosed Gains from Investment Securities across 5 years of filings, most recently posting -$46870.0 for Q3 2025.

• In Q3 2025, Gains from Investment Securities fell 166.67% year-over-year to -$46870.0; the TTM figure through Dec 2025 stood at -$115301.0 (down 248.19% YoY), while the FY2025 annual figure was -$115301.0, down 248.19% from the prior year.
• Gains from Investment Securities came in at -$46870.0 for Q3 2025 at Pasithea Therapeutics, down from $8436.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $335317.0 in Q3 2022 to a low of -$2.6 million in Q4 2021.
• Average Gains from Investment Securities over 5 years is -$218439.5, with a median of -$14061.0 recorded in 2024.
• Year-over-year, Gains from Investment Securities surged 256.25% in 2024 and plunged 187.72% in 2025.
• Over 5 years, Gains from Investment Securities stood at -$2.6 million in 2021, then jumped by 62.09% to -$980509.0 in 2022, then jumped by 105.64% to $55307.0 in 2023, then sank by 102.54% to -$1406.0 in 2024, then tumbled by 3233.57% to -$46870.0 in 2025.
• Per Business Quant data, the three most recent Gains from Investment Securities figures were -$46870.0 in Q3 2025, $8436.0 in Q2 2025, and -$76867.0 in Q1 2025.